Our study shows that CLIP-170 can be acetylated in cells; however, the level of CLIP-170 acetylation is not affected by the HDAC6 inhibitor tubacin, although the deacetylase activity is necessary for the role of HDAC6 in regulating pancreatic cancer cell motility. Here, CLIP1 is linked to familial pancreatic carcinoma.